This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of chiral molecules. Its structure, featuring a trifluoromethyl group and an amino acid moiety, makes it valuable for designing enzyme inhibitors and receptor modulators. It is often employed in the creation of drugs targeting neurological disorders, such as anxiety and depression, due to its potential interaction with neurotransmitter systems. Additionally, it serves as a building block in the production of peptidomimetics, which mimic peptides and are used in drug discovery for their enhanced stability and bioavailability. Its chiral nature also makes it useful in asymmetric synthesis, enabling the production of enantiomerically pure compounds.